#2924
Everolimus in Patients with Advanced Neuroendocrine Neoplasia: A Real-World Study and Analysis of Long Responders
Introduction:
Everolimus is a valid therapeutic option for neuroendocrine tumors (NETs); however, data regarding the long responsders in a real-world setting, outside regulatory trials, are scanty.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Rinzivillo M
Authors:
Rinzivillo M,
De Felice I,
Magi L,
Prosperi D,
Iannicelli E,
Keywords:
everolimus,
neuroendocrine neoplasia,
progressive disease,
target therapy,
#2819
Occurrence of Pancreatic Exocrine Insufficiency in Patients with Advanced Neuroendocrine Tumours Treated with Somatostatin Analogue
Introduction:
Neuroendocrine neoplasia (NENs) are heterogeneous tumours caracterized by a relatively indolent rate of growth. Usually, in G1 and G2 GEP-NENs, first-line therapy is SSAs, considering their efficacy, good safety profile, and antiproliferative effects. SSA treatment inhibits the production and excretion of pancreatic enzymes and PEI is known to be an adverse effect of SSA treatment.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Rinzivillo M
Authors:
De Felice I,
Rinzivillo M,
Pratesi M,
Magi L,
Annibale B,
Keywords:
Pancreatic Exocrine Insufficiency,
#2065
Sunitinib in Patients with Pre-Treated Pancreatic Neuroendocrine Tumors: A Real-World Study
Introduction:
Besides data reported in a Phase-III trial, data on sunitinib in pancreatic Neuroendocrine Tumors (panNETs) are scanty.
Conference:
15th Annual ENETSConcerence (2018)
Presenting Author:
Rinzivillo M
Authors:
Rinzivillo M,
Gritti S,
Pusceddu S,
Spallanzani A,
Ibrahim T,
Keywords:
Sunitinib,
neuroendocrine tumors,
pancreas,
progressive disease,
target therapy,
#2057
Morphological Factors Related to Nodal Metastases in Neuroendocrine Neoplasms of the Appendix. A Multicenter Retrospective Study
Introduction:
Appendiceal NETs are usually diagnosed accidentally after appendectomy; the indications for right hemicolectomy are currently based on several parameters (tumor size, grading, Ki-67, localization, mesoappendiceal invasion, lympho-vascular infiltration). Available guidelines are based on scarce evidence inferred by small, retrospective, single institution studies.
Conference:
15th Annual ENETSConcerence (2018)
Presenting Author:
Brighi N
Authors:
Brighi N,
Rossi G,
Grillo F,
Pusceddu S,
Rinzivillo M,
Keywords:
neuroendocrine neoplasm,
appendix,
predictive factors,
lymph node,
surgery,
nodal metastases,
